S P Leitner

400 citations
9 papers · 289 indexed · h-index 4
Topics
Testicular diseases and treatments (5 papers)Neuroblastoma Research and Treatments (4 papers)Prostate Cancer Treatment and Research (2 papers)
Partner nations
United StatesGermany

In The Last Decade

S P Leitner

9 papers receiving 278 citations

Peers

S P Leitner
Comparison fields: 5 of 41
  • Surgery 240
  • Reproductive Medicine 87
  • Neurology 81
  • Molecular Biology 73
  • Pulmonary and Respiratory Medicine 55
Replace A. Greist with:
A. Greist United States
Ralf Witthuhn Germany
Hope Feldman United States
Petra Neuser Germany
Eva Hoff Wanderås Norway
Richie Jp United States
Antonio Wachtel Peru
Julian Money‐Kyrle United Kingdom
Roy W. Skoglund United States
Hector M. Tarraza United States
S P Leitner relative to A. Greist United States A. Greist's profile →
Citations per field
00.5×1.5×
A. Greist · 1×
Citations per year

Countries citing papers authored by S P Leitner

Since Specialization
Citations

This map shows the geographic impact of S P Leitner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S P Leitner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S P Leitner more than expected).

Fields of papers citing papers by S P Leitner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S P Leitner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S P Leitner. The network helps show where S P Leitner may publish in the future.

Co-authorship network of co-authors of S P Leitner

This figure shows the co-authorship network connecting the top 25 collaborators of S P Leitner. A scholar is included among the top collaborators of S P Leitner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S P Leitner. S P Leitner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
#WorkIndexed citations
1 1
2 3
3 2
4 1
5 183
6 1
7 53
8 38
9
Phase II trial of 4'-deoxydoxorubicin in patients with advanced breast cancer.
7

About S P Leitner

S P Leitner is a scholar working on Neurology, Hematology and Oncology, having authored 9 papers that have together received 289 indexed citations. Recurring topics across this work include Testicular diseases and treatments (5 papers), Neuroblastoma Research and Treatments (4 papers) and Prostate Cancer Treatment and Research (2 papers). The work is most often cited by research in Reproductive Medicine (87 citations), Surgery (240 citations) and Neurology (81 citations). S P Leitner has collaborated with scholars based in United States and Germany. Frequent co-authors include George J. Bosl, Nancy L. Geller, Robert W. Carey, Howard I. Scher, Alan Yagoda, N. Vogelzang, James R. Auman, Dean F. Bajorin, Daiva Bajorunas and Robert B. Golbey. Their work appears in journals such as Journal of Clinical Oncology, The Journal of Urology and Clinical Microbiology and Infection.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026